Sandra Oršulić

ORCID: 0000-0001-5119-8721 · 4 papers in corpus
2026
Cancer research ·doi:10.1158/0008-5472.can-25-1527

Mitigating DNA damage in the fallopian tube epithelium (FTE) is essential for preventing tubo-ovarian high-grade serous carcinoma (HGSC). In this study, we demonstrated that the stimulator of interferon genes (STING) is abundantly expressed…

supplementary-materials 2026
·doi:10.1158/0008-5472.32675390

Quantification of IHC staining for STING conducted on a tumor microarray including cores from healthy FT, FT from patients with gynecological inflammation resulting from endometriosis or chronic salpingitis, and Stage I/Stage II HGSC

2022
Cells ·doi:10.3390/cells11244009

Ciliated cell markers expressed in epithelial ovarian cancers (EOC) are associated with improved survival. We examined the distribution of cells expressing ciliated cell markers in various EOC histologies and stages. Immunohistochemistry an…

article 2015
Fertility and sterility ·doi:10.1016/j.fertnstert.2015.09.023

ObjectiveTo evaluate whether endometriosis-associated genetic variation affects risk of ovarian cancer.DesignPooled genetic analysis.SettingUniversity hospital.Patient(s)Genetic data from 46,176 participants (15,361 ovarian cancer cases and…